IMPORTANT - EIN Presswire is proud to announce the launch of its AI-powered press release generator. Try it now!

IMPORTANT - EIN Presswire is proud to announce the launch of its AI-powered press release generator. Try it now!

World Media Directory · RSS · Email Newsletters

There were 1,124 press releases posted in the last 24 hours and 399,728 in the last 365 days.

Press Releases on February 25, 2021

1,035 Press Releases

Published on February 25, 2021 - 21:02 GMT

Sprouts Farmers Market, Inc. Reports Fourth Quarter and Full Year 2020 Results

PHOENIX, Ariz., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the 14-week fourth quarter and 53-week year ended January 3, 2021. Period-over-period increases stated herein reflect the comparison …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on February 25, 2021 - 21:02 GMT

Sunrun Reports Fourth Quarter and Full Year 2020 Financial Results

Customer Additions of Approximately 23,500 in Q4, Bringing Total Customers to over 550,000, 18% year-over-year growth in Customers pro-forma for Vivint Solar Net Subscriber Value of $9,051 resulting in Total Value Generated of $170 million during Q4 Annual …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

Unity Bancorp Declares Cash Dividend

CLINTON, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Unity Bancorp, Inc. (NASDAQ: UNTY), parent company of Unity Bank, announced that its Board of Directors has declared a cash dividend of $0.08 per common share. Such dividend is payable on March 26, 2021, to …

Distribution channels: Banking, Finance & Investment Industry ...
Published on February 25, 2021 - 21:01 GMT

Capital increase of 80,553 shares (equivalent to approximately 0.23% of the existing shares) in Orphazyme A/S as a result of an ...

Orphazyme A/S Company announcement No. 04/2021 Company …

Distribution channels: Technology
Published on February 25, 2021 - 21:01 GMT

Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million

– 2020 First Full-Year of Profitability, Driven by Xtampza® ER Revenue Growth and the Nucynta® Acquisition – – Collegium Reiterates Previously Issued 2021 Guidance – – Conference Call Scheduled for Today at 4:30 p.m. ET – STOUGHTON, Mass., Feb. 25, 2021 ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 25, 2021 - 21:01 GMT

Eargo Reports Fourth Quarter and Full Year 2020 Financial Results

Recent Highlights: Net revenues of $22.4 million in the fourth quarter and $69.2 million for the full year of 2020, representing 110.8% and 110.9% increases, respectively, over the corresponding periods of 2019 Gross systems shipped of 12,096 in the fourth …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

Marketing applications for pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) under review by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). PDUFA target action date is May 14, 2021 Top-line …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

TPI Composites, Inc. Announces Fourth Quarter and Full Year 2020 Earnings Results – Double Digit Full Year Net Sales Growth

SCOTTSDALE, Ariz., Feb. 25, 2021 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (Nasdaq: TPIC), the only independent manufacturer of composite wind blades with a global footprint, today reported financial results for the fourth quarter and full year ended …

Distribution channels: Business & Economy, Consumer Goods ...
Published on February 25, 2021 - 21:01 GMT

Sientra to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021

SANTA BARBARA, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that it will release financial results for the fourth …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on February 25, 2021 - 21:01 GMT

Natus Medical Announces Fourth Quarter 2020 Financial Results

Q4-2020 Key Results Revenue (millions) $118.7 Revenue increased 15.5% compared to 3rd quarter Generated $16.3 million in operating cash flow Reduced debt by $10.0 million during the quarter Acquired Babybe GmbH during the quarter GAAP EPS $0.15 Non …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

MediWound to Participate in Upcoming March Investment Conferences

YAVNE, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, today announced that the Company will …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on February 25, 2021 - 21:01 GMT

Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates

Expects to Provide Complete Response to FDA Requests on IND Application for VY-HTT01 for Huntington’s Disease in the First Half of 2021 Continues to Progress Pipeline and Platform Activities with Expected Presentations of Data in the First Half of 2021 …

Distribution channels: Business & Economy, Technology ...
Published on February 25, 2021 - 21:01 GMT

Aqua Metals Announces 2020 Results

Recent Highlights: Completed V1.25L Aqualyzer program; achieved a 100% improvement in lead production throughput, in addition to improved equipment and operating costs Continued progress with potential licensing partners; ongoing discussions with several …

Distribution channels: Business & Economy, Electronics Industry ...
Published on February 25, 2021 - 21:01 GMT

Sugarbud Enters Canada’s Largest Recreational Cannabis Market, Signs Supply Agreement with Ontario

CALGARY, Alberta, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.WS, SUGR.DB) ("Sugarbud" or the "Company") is pleased to announce that it has signed a definitive supply agreement with Ontario …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

Mammoth Energy Services, Inc. Announces Fourth Quarter and Full Year 2020 Operational and Financial Results

OKLAHOMA CITY, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Mammoth Energy Services, Inc. (“Mammoth” or the “Company”) (NASDAQ: TUSK) today reported financial and operational results for the fourth quarter and full year ended December 31, 2020. Financial Highlights …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results

Positive momentum continues for U.S. launch of FINTEPLA® (fenfluramine) oral solution in Dravet syndrome, with total net product sales of $8.1 million in the fourth quarter; total net sales of $9.6 million since launch in July 2020 As of December 31, 2020, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 25, 2021 - 21:01 GMT

Oyster Point Pharma to Participate in the 41st Annual Cowen Healthcare Conference

PRINCETON, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

MacroGenics Provides Update on Corporate Progress and 2020 Financial Results

MARGENZA™ approved in December 2020; commercial launch expected March 2021 July 2021 PDUFA target action dates for partnered products retifanlimab and teplizumab Multiple clinical updates across portfolio anticipated in 2021 Conference call scheduled for …

Distribution channels:
Published on February 25, 2021 - 21:01 GMT

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates

SAN CARLOS, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte …

Distribution channels: Business & Economy, Technology ...
Published on February 25, 2021 - 21:01 GMT

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing during Q2 2021 Cash and cash equivalents of $126.9 million as of December 31, 2020 Conference call and webcast focused on our COVID-19 …

Distribution channels:

Previous 6 7 8 9 10 11 12 13 14 15 16 Next

Previous Day 2021 Calendar Next Day